Cargando…

Valuing EQ-5D-Y: the current state of play

BACKGROUND: For nearly a decade, value sets for the EQ-5D-Y were not available, reflecting challenges in valuing child HRQoL. A methodological research programme led to publication of a valuation protocol in 2020, which was rapidly taken up by local study teams. By the end of 2022, between 11 and 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Devlin, N., Pan, T., Kreimeier, S., Verstraete, J., Stolk, E., Rand, K., Herdman, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260978/
https://www.ncbi.nlm.nih.gov/pubmed/35794607
http://dx.doi.org/10.1186/s12955-022-01998-8
_version_ 1784742164409876480
author Devlin, N.
Pan, T.
Kreimeier, S.
Verstraete, J.
Stolk, E.
Rand, K.
Herdman, M.
author_facet Devlin, N.
Pan, T.
Kreimeier, S.
Verstraete, J.
Stolk, E.
Rand, K.
Herdman, M.
author_sort Devlin, N.
collection PubMed
description BACKGROUND: For nearly a decade, value sets for the EQ-5D-Y were not available, reflecting challenges in valuing child HRQoL. A methodological research programme led to publication of a valuation protocol in 2020, which was rapidly taken up by local study teams. By the end of 2022, between 11 and 17 EQ-5D-Y value sets will be available, more than for any other child HRQoL measure. It is timely to review the experience of those using the protocol to identify early learnings and remaining issues where more research is needed. METHODS: In June 2021, the EuroQol Group organised a three-day workshop, bringing together all those involved in EQ-5D-Y value set studies and related methodological research concerning EQ-5D-Y and valuation. Workshop discussions were captured by note taking and recording all sessions and online chat. A narrative summary of all sessions was produced and synthesised to identify points of agreement and aspects of methods where uncertainty remains. RESULTS: There was broad agreement that DCE is working well as the principal valuation method. However, the most appropriate means of anchoring the latent scale values produced by DCE remains unclear. Some studies have deviated from the protocol by extending the number of states included in TTO tasks, to better support modelling of DCE and TTO. There is ongoing discussion about the relative merits of alternative variants of TTO and other methods for anchoring. Very few studies have consulted with local end-users to gauge the acceptability of methods used to value EQ-5D-Y. CONCLUSIONS: Priority areas for research include testing alternative methods for anchoring DCE data; exploring the preferences of adolescents; and scale differences in values for EQ-5D-Y and adult EQ-5D states, and implications of such differences for the use of EQ-5D-Y values in HTA. Given the normative elements of the protocol, engaging with HTA bodies and other local users should be the first step for all future value set studies. Value sets undertaken to date are for the three-level EQ-5D-Y. However, the issues discussed in this paper are equally relevant to valuation of the five-level version of EQ-5D-Y; indeed, similar challenges are encountered valuing any measure of child HRQoL.
format Online
Article
Text
id pubmed-9260978
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92609782022-07-07 Valuing EQ-5D-Y: the current state of play Devlin, N. Pan, T. Kreimeier, S. Verstraete, J. Stolk, E. Rand, K. Herdman, M. Health Qual Life Outcomes Research BACKGROUND: For nearly a decade, value sets for the EQ-5D-Y were not available, reflecting challenges in valuing child HRQoL. A methodological research programme led to publication of a valuation protocol in 2020, which was rapidly taken up by local study teams. By the end of 2022, between 11 and 17 EQ-5D-Y value sets will be available, more than for any other child HRQoL measure. It is timely to review the experience of those using the protocol to identify early learnings and remaining issues where more research is needed. METHODS: In June 2021, the EuroQol Group organised a three-day workshop, bringing together all those involved in EQ-5D-Y value set studies and related methodological research concerning EQ-5D-Y and valuation. Workshop discussions were captured by note taking and recording all sessions and online chat. A narrative summary of all sessions was produced and synthesised to identify points of agreement and aspects of methods where uncertainty remains. RESULTS: There was broad agreement that DCE is working well as the principal valuation method. However, the most appropriate means of anchoring the latent scale values produced by DCE remains unclear. Some studies have deviated from the protocol by extending the number of states included in TTO tasks, to better support modelling of DCE and TTO. There is ongoing discussion about the relative merits of alternative variants of TTO and other methods for anchoring. Very few studies have consulted with local end-users to gauge the acceptability of methods used to value EQ-5D-Y. CONCLUSIONS: Priority areas for research include testing alternative methods for anchoring DCE data; exploring the preferences of adolescents; and scale differences in values for EQ-5D-Y and adult EQ-5D states, and implications of such differences for the use of EQ-5D-Y values in HTA. Given the normative elements of the protocol, engaging with HTA bodies and other local users should be the first step for all future value set studies. Value sets undertaken to date are for the three-level EQ-5D-Y. However, the issues discussed in this paper are equally relevant to valuation of the five-level version of EQ-5D-Y; indeed, similar challenges are encountered valuing any measure of child HRQoL. BioMed Central 2022-07-06 /pmc/articles/PMC9260978/ /pubmed/35794607 http://dx.doi.org/10.1186/s12955-022-01998-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Devlin, N.
Pan, T.
Kreimeier, S.
Verstraete, J.
Stolk, E.
Rand, K.
Herdman, M.
Valuing EQ-5D-Y: the current state of play
title Valuing EQ-5D-Y: the current state of play
title_full Valuing EQ-5D-Y: the current state of play
title_fullStr Valuing EQ-5D-Y: the current state of play
title_full_unstemmed Valuing EQ-5D-Y: the current state of play
title_short Valuing EQ-5D-Y: the current state of play
title_sort valuing eq-5d-y: the current state of play
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260978/
https://www.ncbi.nlm.nih.gov/pubmed/35794607
http://dx.doi.org/10.1186/s12955-022-01998-8
work_keys_str_mv AT devlinn valuingeq5dythecurrentstateofplay
AT pant valuingeq5dythecurrentstateofplay
AT kreimeiers valuingeq5dythecurrentstateofplay
AT verstraetej valuingeq5dythecurrentstateofplay
AT stolke valuingeq5dythecurrentstateofplay
AT randk valuingeq5dythecurrentstateofplay
AT herdmanm valuingeq5dythecurrentstateofplay